High-dose chemotherapy with autologous bone marrow transplantation

Area of Science:

• Oncology
• Hematology
• Cancer Therapeutics

Background:

• High-dose chemotherapy with autologous bone marrow support is a recognized treatment modality.
• This approach has demonstrated high initial response and complete response rates across various cancer types.

Purpose of the Study:

• To review tumor types where long-term disease-free survival has been achieved with high-dose chemotherapy and autologous bone marrow support.
• To identify other cancers and prognostic subgroups that could potentially benefit from this intensive treatment strategy.

Main Methods:

• Literature review of studies employing high-dose chemotherapy with autologous bone marrow support.
• Analysis of patient outcomes, focusing on long-term disease-free survival.

Main Results:

• Certain tumor types exhibit sustained disease-free survival following this intensive therapy.
• The review highlights specific cancers and subgroups where this approach is most effective.

Conclusions:

• High-dose chemotherapy with autologous bone marrow support can lead to long-term remission in select cancer types.
• Consideration of this intensified treatment is warranted for specific tumors and relapsed cases.